Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Zurex Pharma
Zurex Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zuragard
Fenofibrate
2019-04-26
2024-2033
Hypercholesterolemia
,
Coronary artery disease
,
Dyslipidemias
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
,
Periodontal diseases
,
Infectious skin diseases
,
Gram-negative bacterial infections
,
Oral candidiasis
,
Gram-positive bacterial infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fenofibrate
surgical wound infection
Bevifimod
allergic rhinitis seasonal
,
nasal obstruction
,
sneezing
,
dental anxiety
,
restless legs syndrome
,
spinal cord injuries
,
type 1 diabetes mellitus
,
hiv infections
,
non-small-cell lung carcinoma
,
osteoarthritis
,
breast neoplasms
,
depression
,
neurologic manifestations
,
wounds and injuries
,
central nervous system diseases
,
spinal cord diseases
,
sleep wake disorders
,
inguinal hernia
,
peripheral nervous system diseases
,
radiculopathy
,
psoriasis
,
fibromyalgia
,
healthy volunteers/patients
,
neuralgia
,
partial epilepsies
,
diabetic neuropathies
,
epilepsy
,
pain
,
sleep initiation and maintenance disorders
,
seizures
,
postherpetic neuralgia
,
postoperative pain
,
anxiety disorders
,
low back pain
,
generalized anxiety disorder
,
complex partial epilepsy
,
back pain
,
breast feeding
,
bronchiolitis obliterans syndrome
,
neoplasms
,
bone neoplasms
,
intractable pain
,
phantom limb
,
burns
,
renal insufficiency
,
pharmacovigilance
Riboprine
aspergillosis
,
invasive pulmonary aspergillosis
,
inflammation
,
pleural effusion
,
immunosuppression therapy
,
ventilator-associated pneumonia
,
pneumonia
,
pulmonary aspergillosis
Crystalloid
healthy volunteers/patients
,
osteoarthritis
,
major depressive disorder
,
prostatic hyperplasia
,
skin aging
,
carpal tunnel syndrome
,
premature ejaculation
,
neuralgia
,
hyperalgesia
,
cicatrix
,
torticollis
,
depression
,
systemic lupus erythematosus
,
muscle spasticity
,
stroke
,
urinary incontinence
,
cerebral palsy
,
migraine disorders
,
multiple sclerosis
,
neurogenic urinary bladder
,
overactive urinary bladder
Zuraprep
surgical wound infection
Chloraprep
tissue adhesions
,
healthy volunteers/patients
,
infections
Corsodyl
catheterization
,
infections
,
communicable diseases
,
hand hygiene
,
skin diseases
,
healthy volunteers/patients
,
ventilator-associated pneumonia
,
wounds and injuries
,
sepsis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use